AML-119 The Impact of Post-Remission Granulocyte Colony-Stimulating Factor (G-CSF) Use (G-CSFu) in the Phase 3 Studies of Venetoclax (Ven) Combination Treatments in Patients (Pts) With Newly Diagnosed Acute Myeloid Leukemia (AML)

Autor:	Courtney DiNardo, Keith Pratz, Panayiotis Panayiotidis, Xudong Wei, Vladimir Vorobyev, Àrpád Illés, Inho Kim, Vladimir Ivanov, Grace Ku, Catherine Miller, Meng Zhang, Fernando Tatsch, Jalaja Potluri, Xenia Schmidt, Christian Recher
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S214
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)01223-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::900b767226e54e6029ef770bb9c35045 https://doi.org/10.1016/s2152-2650(22)01223-x Zobrazit plný text záznamu Full Text from ScienceDirect